The Novitas decision is not all doom and gloom for Pacific Edge

The Novitas decision is not all doom and gloom for Pacific Edge
(Image: Pacific Edge)
Rebecca Howard
News Pacific Edge's Cxbladder tests will no longer be covered by US national health insurance provider Medicare is a “game-changing announcement” but “not all doom and gloom” says Forsyth Barr analysts.On Wednesday, the company confirmed a so-called “local coverage determination” from Novitas – the Medicare administrative contractor – that meant its suite of products does not meet the threshold required for coverage under the US Social Security Act. The stock fell nearly 90% on the news.&...

More Markets

NZ stocks end firm after Sky, Vulcan, annual meetings
Markets Market Close

NZ stocks end firm after Sky, Vulcan, annual meetings

There were 84 rises and 54 falls on the main board.

Jamie Gray 31 Oct 2025
Rising volumes push Port of Tauranga profit outlook higher
Primary Sector

Rising volumes push Port of Tauranga profit outlook higher

Port of Tauranga expects its full-year net profit after tax to fall somewhere between $137 million and $147m.The NZX-listed port company’s container volumes increased 9% to 319,649 TEUs in the first three months to Sept 30.Total trade increased 5.9% in volume compared to the same...

Staff reporters 31 Oct 2025
SkyCity faces Adelaide reckoning by year-end
Markets

SkyCity faces Adelaide reckoning by year-end

Casino operator releases details about regulatory situation in Adelaide.

Dileepa Fonseka 31 Oct 2025